CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

SciBase Announces Nevisense Use in NIH-Led Study of Environmental Exposure Effects on Skin

By Public Technologies
  • SciBase announced a planned NIH-led study with the Swiss Institute of Allergy and Asthma Research to assess environmental exposure’s effects on skin.
  • The THREAT study will use Nevisense as a primary outcome measure to evaluate those effects; findings remain prospective.
  • A deeper collaboration with Castle Biosciences generated an additional order worth about SEK 5 million for another clinical study.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SciBase Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 202611120200BITN____UKPR__SV_20261111-BIT-8062-0) on November 12, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk